The DOI matches its Crossref record; 37 of the 38 references it cites were found in a registry or an index.
Human 3α-hydroxysteroid dehydrogenase isoforms (AKR1C1-AKR1C4) of the aldo-keto reductase superfamily: functional plasticity and tissue distribution reveals roles in the inactivation and formation of male and female sex hormones
Open accessAbstract
The kinetic parameters, steroid substrate specificity and identities of reaction products were determined for four homogeneous recombinant human 3α-hydroxysteroid dehydrogenase (3α-HSD) isoforms of the aldo-keto reductase (AKR) superfamily. The enzymes correspond to type 1 3α-HSD (AKR1C4), type 2 3α(17β)-HSD (AKR1C3), type 3 3α-HSD (AKR1C2) and 20α(3α)-HSD (AKR1C1), and share at least 84% amino acid sequence identity. All enzymes acted as NAD(P)(H)-dependent 3-, 17- and 20-ketosteroid reductases and as 3α-, 17β- and 20α-hydroxysteroid oxidases. The functional plasticity of these isoforms highlights their ability to modulate the levels of active androgens, oestrogens and progestins. Salient features were that AKR1C4 was the most catalytically efficient, with kcat/Km values for substrates that exceeded those obtained with other isoforms by 10–30-fold. In the reduction direction, all isoforms inactivated 5α-dihydrotestosterone (17β-hydroxy-5α-androstan-3-one; 5α-DHT) to yield 5α-androstane-3α,17β-diol (3α-androstanediol). However, only AKR1C3 reduced ∆4-androstene-3,17-dione to produce significant amounts of testosterone. All isoforms reduced oestrone to 17β-oestradiol, and progesterone to 20α-hydroxy-pregn-4-ene-3,20-dione (20α-hydroxyprogesterone). In the oxidation direction, only AKR1C2 converted 3α-androstanediol to the active hormone 5α-DHT. AKR1C3 and AKR1C4 oxidized testosterone to ∆4-androstene-3,17-dione. All isoforms oxidized 17β-oestradiol to oestrone, and 20α-hydroxy…
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“17HSD5 may account for much of the extratesticular, peripheral conversion of androstenedione to testosterone, although its catalytic efficiency as a 17HSD is poor (528) compared with its 20␣HSD activity with progesterone and DOC (520) or its prostaglandin dehydrogenase activity, reducing prostaglandin H 2 to prostaglandin F 2␣ (529).”
From The Molecular Biology, Biochemistry, and Physiology of Human Steroidogenesis and Its Disorders (2011) · cites this paper as [528]
In the citing paper
“AKR1C1-AKR1C4 act as 3-keto, 17-keto and 20-ketosteroid reductases to varying extents”
From Role of aldo-keto reductase family 1 (AKR1) enzymes in human steroid metabolism (2014) · cites this paper as [14]
In the citing paper
“AKR1C enzymes (AKR1C1-AKR1C4) function in vivo as 3-keto-, 17-keto- and 20-ketosteroid reductases to form 3α/β, 17β- and 20α-hydroxy-metabolites to varying extents and thus metabolize a broad spectrum of natural and synthetic therapeutic steroids”
From Role of aldo-keto reductase family 1 (AKR1) enzymes in human steroid metabolism (2014) · cites this paper as [14]
In the citing paper
“These enzymes are expressed in different tissues, while AKR1C4 is mainly liver specific”
From Role of aldo-keto reductase family 1 (AKR1) enzymes in human steroid metabolism (2014) · cites this paper as [14]
In the citing paper
“AKR1C1, but also AKR1C2 and AKR1C3 catalyze progesterone reduction to form the less potent progestagen 20α-hydroxy-pregn-4-ene-3-one”
From Role of aldo-keto reductase family 1 (AKR1) enzymes in human steroid metabolism (2014) · cites this paper as [14]
In the citing paper
“AKR1C3 is the most efficient enzyme for this reaction (KM = 9 μM, kcat = 0.068 mM−1; kcat/KM = 76 min−1 mm−1).”
From Role of aldo-keto reductase family 1 (AKR1) enzymes in human steroid metabolism (2014) · cites this paper as [14]
In the citing paper
“AKR1C enzymes also act as 17-ketosteroid reductases to reduce the weak estrogen, estrone to form the potent estrogen, 17β-estradiol in peripheral tissues”
From Role of aldo-keto reductase family 1 (AKR1) enzymes in human steroid metabolism (2014) · cites this paper as [14]
In the citing paper
“Other AKR1C enzymes have much lower activities for 17β-estradiol formation”
From Role of aldo-keto reductase family 1 (AKR1) enzymes in human steroid metabolism (2014) · cites this paper as [14]
In the citing paper
“AKR1C enzymes are multifunctional and also function as 20α- and 17β-HSDs, with different efficiencies, stereoselectivities and tissue specific expression [104].”
From Human steroid biosynthesis, metabolism and excretion are differentially reflected by serum and urine steroid metabolomes: a comprehensive review (2019) · cites this paper as [104]
In the citing paper
“the direct 20α-reduction of progesterone terminates its progestogenic activity”
From Human steroid biosynthesis, metabolism and excretion are differentially reflected by serum and urine steroid metabolomes: a comprehensive review (2019) · cites this paper as [104]
In the citing paper
“is predominantly catalyzed by AKR1C1 [104,115].”
From Human steroid biosynthesis, metabolism and excretion are differentially reflected by serum and urine steroid metabolomes: a comprehensive review (2019) · cites this paper as [104]
In the citing paper
“AKR1C1 is the predominant 20-ketosteroid reductase in human [104].”
From Human steroid biosynthesis, metabolism and excretion are differentially reflected by serum and urine steroid metabolomes: a comprehensive review (2019) · cites this paper as [104]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Statistical estimations in enzyme kinetics
Wilkinson, G. (1961) · Biochemical Journal · doi:10.1042/bj0800324 · Cited by 3,535
Steroid hormone metabolites are barbiturate-like modulators of the GABA receptor
Majewska, M. D., Harrison, N. L., Schwartz, R. D., Barker, J. L., & Paul, S. M. (1986) · Science · doi:10.1126/science.2422758 · Cited by 2,225
Majewska, M. D. (1992) · Progress in Neurobiology · doi:10.1016/0301-0082(92)90025-a · Cited by 1,089
Neurosteroids and GABAA receptor function
Lambert, J. J., Belelli, D., Hill-Venning, C., & Peters, J. A. (1995) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(00)89058-6 · Cited by 746
Comparative anatomy of the aldo–keto reductase superfamily
Jez, J. M., BENNETT, M. J., Schlegel, B. P., Lewis, M., & Penning, T. M. (1997) · Biochemical Journal · doi:10.1042/bj3260625 · Cited by 603
Self-citationThe key role of 17β-hydroxysteroid dehydrogenases in sex steroid biology
Labrie, F., Luu-The, V., Lin, S.-X., Claude, L., Simard, J., Breton, R., & Bélanger, A. (1997) · Steroids · doi:10.1016/s0039-128x(96)00174-2 · Cited by 480
Selective serotonin reuptake inhibitors directly alter activity of neurosteroidogenic enzymes
Griffin, L. D., & Mellon, S. H. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.23.13512 · Cited by 387
A new nomenclature for the aldo-keto reductase superfamily
Jez, J. M., Flynn, T. G., & Penning, T. M. (1997) · Biochemical Pharmacology · doi:10.1016/s0006-2952(97)84253-0 · Cited by 350
Self-citationDanielsson, H., & Sjövall, J. (1975) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.44.070175.001313 · Cited by 272
Steroid Structure and Androgenic Activity
Liao, S., Liang, T., Fang, S., Castañeda, E., & Shao, T.-C. (1973) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)43521-7 · Cited by 265
Research works printed but not linked: 2
- 29 Leatherbarrow, R. J. (1987) ENZFITTER: A non-linear regression data analysis program for the IBM PC (and true compatibles), BioSoft, Cambridge, U.K.
- 33 Lin, H.-K., Jez, J. M., Overby, A. M., Burczynski, M. E., Peehl, D. M. and Penning, T. M. (2000) Type 3 3 a -hydroxysteroid dehydrogenase (3 a -HSD) accumulates 5 a -DHT and activates the androgen receptor in human prostate cancer PC3 cells. Proc. Am. Assoc. Cancer. Res. 41 , Abstract 1510
Cited by
Sorted by citations
Items 101–200 of 671
Jeddi, F., Soozangar, N., Sadeghi, M. R., Somi, M. H., & Samadi, N. (2017) · DNA repair · doi:10.1016/j.dnarep.2017.03.008 · Cited by 90
Liquid chromatography–mass spectrometry (LC–MS) of steroid hormone metabolites and its applications
Penning, T. M., Lee, S. H., Jin, Y., Gutiérrez, A., & Blair, I. A. (2010) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2010.01.005 · Cited by 90
Self-citationThe human kidney is a progesterone-metabolizing and androgen-producing organ
Quinkler, M., Bumke-Vogt, C., Meyer, B., Bähr, V., Oelkers, W., & Diederich, S. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2002-021970 · Cited by 87
Biological Role of Aldo–Keto Reductases in Retinoic Acid Biosynthesis and Signaling
Ruiz, F. X., Porté, S., Parés, X., & Farrés, J. (2012) · Frontiers in Pharmacology · doi:10.3389/fphar.2012.00058 · Cited by 88
Selective reduction of AKR1C2 in prostate cancer and its role in DHT metabolism
Ji, Q., Chang, L., Vandenberg, D. J., Stanczyk, F. Z., & Stolz, A. (2003) · The Prostate · doi:10.1002/pros.10192 · Cited by 86
5α-Reduced C21 steroids are substrates for human cytochrome P450c17
Gupta, M. K., Guryev, O. L., & Auchus, R. J. (2003) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2003.07.003 · Cited by 84
Carbonyl reduction pathways in drug metabolism
Malátková, P., & Wsól, V. (2013) · Drug Metabolism Reviews · doi:10.3109/03602532.2013.853078 · Cited by 85
Aberrant pre-receptor regulation of estrogen and progesterone action in endometrial cancer
Šmuc, T., & Rižner, T. L. (2008) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2008.09.019 · Cited by 85
Yee, D. J., Balšánek, V., & Sameš, D. (2004) · Journal of the American Chemical Society · doi:10.1021/ja039799f · Cited by 84
Gender Differences in Multiple Sclerosis
Luchetti, S., van Eden, C. G., Schuurman, K. G., van Strien, M. E., Swaab, D. F., & Huitinga, I. (2014) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0000000000000037 · Cited by 82
Maser, E., Völker, B., & Friebertshäuser, J. (2002) · Biochemistry · doi:10.1021/bi015803t · Cited by 82
Byrns, M. C., & Penning, T. M. (2008) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2008.10.024 · Cited by 82
Self-citationTrauger, J. W., Jiang, A., Stearns, B. A., & LoGrasso, P. V. (2002) · Biochemistry · doi:10.1021/bi026109w · Cited by 81
Expression of Sterol 27-Hydroxylase (CYP27A1) Enhances Cholesterol Efflux
Escher, G., Krozowski, Z. S., Croft, K. D., & Sviridov, D. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m212780200 · Cited by 81
Huang, L., Chen, S., Huang, Y., Luo, W., Jiang, H., Hu, Q., Zhang, P., & Yi, H. L. (2006) · Lung Cancer · doi:10.1016/j.lungcan.2006.06.011 · Cited by 79
Veliça, P., Davies, N., Rocha, P. P., Schrewe, H., Ride, J. P., & Bunce, C. M. (2009) · Molecular Cancer · doi:10.1186/1476-4598-8-121 · Cited by 80
Metabolic conversion as a pre‐receptor control mechanism for lipophilic hormones
Nobel, S., Abrahmsén, L., & Oppermann, U. C. T. (2001) · European Journal of Biochemistry · doi:10.1046/j.1432-1327.2001.02359.x · Cited by 82
Di Costanzo, L., Drury, J. E., Penning, T. M., & Christianson, D. W. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m801778200 · Cited by 79
Self-citationBirtwistle, J., Hayden, R. E., Khanim, F. L., Green, R. M., Pearce, C., Davies, N., Wake, N. C., Schrewe, H., Ride, J. P., Chipman, J. K., et al. (2009) · Mutation research. Fundamental and molecular mechanisms of mutagenesis · doi:10.1016/j.mrfmmm.2008.12.010 · Cited by 79
Copy Number Variation in the Horse Genome
Ghosh, S., Qu, Z., Das, P. J., Fang, E., Juras, R., Cothran, E. G., McDonell, S., Kenney, D. G., Lear, T. L., Adelson, D. L., et al. (2014) · PLoS Genetics · doi:10.1371/journal.pgen.1004712 · Cited by 80
Characterization of a Novel Type of Human Microsomal 3α-Hydroxysteroid Dehydrogenase
Chetyrkin, S. V., Belyaeva, O. V., Gough, W. H., & Kedishvili, N. Y. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m102076200 · Cited by 78
Galectin-1 and Its Involvement in Hepatocellular Carcinoma Aggressiveness
Spano, D., Russo, R., Maso, V. D., Rosso, N., Terracciano, L., Roncalli, M. G., Tornillo, L., Capasso, M., Tiribelli, C., & Iolascon, A. (2009) · Molecular Medicine · doi:10.2119/molmed.2009.00119 · Cited by 76
Qiu, W., Zhou, M., Labrie, F., & Lin, S. (2004) · Molecular Endocrinology · doi:10.1210/me.2004-0032 · Cited by 76
Marti, N., Galván, J. A., Pandey, A. V., Trippel, M., Tapia, C., Müller, M., Perren, A., & Flück, C. E. (2017) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2016.07.029 · Cited by 76
Couture, J., Legrand, P., Cantin, L., Luu-The, V., Labrie, F., & Breton, R. (2003) · Journal of Molecular Biology · doi:10.1016/s0022-2836(03)00762-9 · Cited by 77
Steroid metabolome in fetal and maternal body fluids in human late pregnancy
Hill, M., Pařı́zek, A., Cibula, D., Kancheva, R. L., Jirasek, J. E., Jirkovská, M., Velíková, M., Kubátová, J., Klímková, M., Pašková, A., et al. (2010) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2010.05.007 · Cited by 77
Chen, J., Adikari, M., Pallai, R., Parekh, H. K., & Simpkins, H. (2007) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-007-0554-0 · Cited by 74
Halim, M., Tremblay, M. S., Steffen Jockusch, B., Turro, N. J., & Sameš, D. (2007) · Journal of the American Chemical Society · doi:10.1021/ja071311d · Cited by 74
Schüle, C., Romeo, E., Uzunov, D. P., Eser, D., di Michele, F., Baghai, T. C., Pasini, A., Schwarz, M., Kempter, H., & Rupprecht, R. (2005) · Molecular Psychiatry · doi:10.1038/sj.mp.4001782 · Cited by 73
Inactivation of the anticancer drugs doxorubicin and oracin by aldo–keto reductase (AKR) 1C3
Novotná, R., Wsól, V., Xiong, G., & Maser, E. (2008) · Toxicology Letters · doi:10.1016/j.toxlet.2008.06.858 · Cited by 73
Updated survey of the steroid-converting enzymes in human adipose tissues
Tchernof, A., Mansour, M. F., Pelletier, M., Boulet, M.-M., Nadeau, M., & Luu-The, V. (2015) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2014.11.011 · Cited by 73
Barnard, M., Quanson, J. L., Mostaghel, E., Pretorius, E., Snoep, J. L., & Storbeck, K.-H. (2018) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2018.06.013 · Cited by 72
Muthusamy, S., Andersson, S., Kim, H., Butler, R., Waage, L., Bergerheim, U. S. R., & Gustafsson, J.-Α. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1117772108 · Cited by 73
Bauman, D. R., Steckelbroeck, S., Peehl, D. M., & Penning, T. M. (2006) · Endocrinology · doi:10.1210/en.2006-0627 · Cited by 72
Self-citationAKR1C3 as a potential target for the inhibitory effect of dietary flavonoids
Zemanová, L., Živná, L., Xiong, G., Maser, E., & Wsól, V. (2008) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2008.10.015 · Cited by 72
Rasmusson, A. M., King, M. W., Valovski, I. T., Gregor, K. L., Scioli, E. R., Pineles, S. L., Hamouda, M., Nillni, Y. I., Anderson, G. M., & Pinna, G. (2018) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2018.11.027 · Cited by 72
Minervini, F., Giannoccaro, A., Fornelli, F., Dell’Aquila, M. E., Minoia, P., & Visconti, A. (2006) · Reproductive Biology and Endocrinology · doi:10.1186/1477-7827-4-62 · Cited by 72
Gene expression profiles in testis of pigs with extreme high and low levels of androstenone
Moe, M., Meuwissen, T. H. E., Lien, S., Bendixen, C., Wang, X., Conley, L. N., Berget, I., Tajet, H., & Grindflek, E. H. (2007) · BMC Genomics · doi:10.1186/1471-2164-8-405 · Cited by 71
Polycyclic aromatic hydrocarbon-DNA adduct formation in prostate carcinogenesis
Rybicki, B. A., Nock, N. L., Savera, A. T., Tang, D. L., & Rundle, A. (2005) · Cancer Letters · doi:10.1016/j.canlet.2005.07.029 · Cited by 68
Of marsupials and men: “Backdoor” dihydrotestosterone synthesis in male sexual differentiation
Biason-Lauber, A., Miller, W. L., Pandey, A. V., & Flück, C. E. (2013) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2013.01.017 · Cited by 69
Ji, Q., Chang, L., Stanczyk, F. Z., Ookhtens, M., Sherrod, A. E., & Stolz, A. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-1593 · Cited by 69
Exploring Breast Cancer Estrogen Disposition: The Basis for Endocrine Manipulation
Lønning, P. E., Haynes, B. P., Straume, A. H., Dunbier, A. K., Helle, H., Knappskog, S., & Dowsett, M. (2011) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-11-0043 · Cited by 67
The role of adrenal derived androgens in castration resistant prostate cancer
Barnard, M., Mostaghel, E. A., Auchus, R. J., & Storbeck, K. (2019) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2019.105506 · Cited by 68
Penning, T. M., Jin, Y., Heredia, V. V., & Lewis, M. (2003) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/s0960-0760(03)00236-x · Cited by 67
Self-citationBlouin, K., Blanchette, S., Richard, C., Dupont, P., Luu-The, V., & Tchernof, A. (2005) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00312.2004 · Cited by 67
Zebrafish 17beta-hydroxysteroid dehydrogenases: An evolutionary perspective
Mindnich, R., & Adamski, J. (2008) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2008.12.002 · Cited by 65
Steckelbroeck, S., Oyesanmi, B., Jin, Y., Lee, S. H., Kloosterboer, H. J., & Penning, T. M. (2006) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.105.091587 · Cited by 66
Self-citationDozmorov, M. G., Azzarello, J. T., Wren, J. D., Fung, K. M., Yang, Q., Davis, J., Hurst, R. E., Culkin, D. J., Penning, T. M., & Lin, H. K. (2010) · BMC Cancer · doi:10.1186/1471-2407-10-672 · Cited by 66
Self-citationChen, M., Adeniji, A. O., Twenter, B. M., Winkler, J. D., Christianson, D. W., & Penning, T. M. (2012) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2012.03.085 · Cited by 65
Self-citationApproaches towards molecular amplification for sensing
Goggins, S., & Frost, C. G. (2016) · The Analyst · doi:10.1039/c6an00348f · Cited by 68
Steckelbroeck, S., Jin, Y., Oyesanmi, B., Kloosterboer, H. J., & Penning, T. M. (2004) · Molecular Pharmacology · doi:10.1124/mol.104.004515 · Cited by 64
Self-citationSteroids and Alzheimer’s Disease: Changes Associated with Pathology and Therapeutic Potential
Akwa, Y. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21134812 · Cited by 66
Wang, S., Yang, Q., Fung, K.-M. A., & Lin, H. (2008) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2008.04.004 · Cited by 65
Self-citationZhong, T., Xu, F., Xu, J., Liu, L., & Chen, Y. (2014) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2014.12.022 · Cited by 66
Konings, G. F. J., Brentjens, L. S., Delvoux, B., Linnanen, T., Cornel, K. M. C., Koskimies, P., Bongers, M. Y., Kruitwagen, R. F. P. M., Xanthoulea, S., & Romano, A. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.00940 · Cited by 66
Paulukinas, R. D., Mesaros, C., & Penning, T. M. (2022) · Endocrinology · doi:10.1210/endocr/bqac068 · Cited by 63
Self-citationManesh, D. M., El‐Hoss, J., Evans, K., Richmond, J., Toscan, C. E., Bracken, L. S., Hedrick, A., Sutton, R., Marshall, G. M., Wilson, W. R., et al. (2015) · Blood · doi:10.1182/blood-2014-12-618900 · Cited by 63
He, X., Węgiel, J., & Yang, S. (2005) · Brain Research · doi:10.1016/j.brainres.2005.01.022 · Cited by 67
Verma, K., Zang, T., Penning, T. M., & Trippier, P. C. (2019) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.9b00090 · Cited by 63
Self-citationJin, Y., & Penning, T. M. (2006) · Biochemistry · doi:10.1021/bi060591r · Cited by 60
Self-citationByrns, M. C., Mindnich, R., Duan, L., & Penning, T. M. (2012) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2011.12.012 · Cited by 60
Self-citationResponses of sex steroid hormones to different intensities of exercise in endurance athletes
Sato, K., Iemitsu, M., Katayama, K., Ishida, K., Kanao, Y., & Saito, M. (2016) · Experimental Physiology · doi:10.1113/ep085361 · Cited by 59
Pingaew, R., Mandi, P., Nantasenamat, C., Prachayasittikul, S., Ruchirawat, S., & Prachayasittikul, V. (2014) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2014.05.019 · Cited by 60
Shiiba, M., Yamagami, H., Yamamoto, A., Minakawa, Y., Okamoto, A., Kasamatsu, A., Sakamoto, Y., Uzawa, K., Takiguchi, Y., & Tanzawa, H. (2017) · Oncology Reports · doi:10.3892/or.2017.5480 · Cited by 60
Usami, N., Yamamoto, T., Shintani, S., Higaki, Y., Ishikura, S., Patagiri, Y., & Hara, A. (2002) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.25.441 · Cited by 59
Nahoum, V., Gangloff, A., Legrand, P., Zhu, D., Cantin, L., Zhorov, B. S., Luu-The, V., Labrie, F., Breton, R., & Lin, S. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m105610200 · Cited by 59
Cooper, W. C., Jin, Y., & Penning, T. M. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m703414200 · Cited by 58
Self-citationThe other side of progestins: effects in the brain.
Giatti, S., Melcangi, R., & Pesaresi, M. (2016) · Journal of Molecular Endocrinology · doi:10.1530/jme-16-0061 · Cited by 53
Pre-receptor regulation of the androgen receptor
Penning, T. M., Jin, Y., Rižner, T. L., & Bauman, D. R. (2007) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2007.10.008 · Cited by 60
Self-citationCarbonyl reduction of naltrexone and dolasetron by oxidoreductases isolated from human liver cytosol
Breyer-Pfaff, U., & Nill, K. (2004) · Journal of Pharmacy and Pharmacology · doi:10.1211/0022357045020 · Cited by 57
Zhang, L., Jin, Y., Huang, M. T., & Penning, T. M. (2012) · Frontiers in Pharmacology · doi:10.3389/fphar.2012.00193 · Cited by 68
Self-citationProgesterone metabolism in adipose cells
Zhang, Y., Nadeau, M., Faucher, F., Lescelleur, O., Biron, S., Daris, M., Rhéaume, C., Luu-The, V., & Tchernof, A. (2008) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2008.09.034 · Cited by 55
Veitch, Z. W. N., Guo, B., Hembruff, S. L., Bewick, A. J., Heibein, A. D., Eng, J., Cull, S., Maclean, D. A., & Parissenti, A. M. (2009) · Pharmacogenetics and Genomics · doi:10.1097/fpc.0b013e32832c484b · Cited by 57
Pippione, A. C., Carnovale, I. M., Bonanni, D., Sini, M., Goyal, P., Marini, E., Pors, K., Adinolfi, S., Zonari, D., Festuccia, C., et al. (2018) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2018.03.040 · Cited by 57
Evans, K., Duan, J., Pritchard, T., Jones, C. D., McDermott, L., Gu, Z., Toscan, C. E., El-Zein, N., Mayoh, C., Erickson, S. W., et al. (2019) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-19-0551 · Cited by 57
Wiebe, J. P., & Lewis, M. J. (2003) · BMC Cancer · doi:10.1186/1471-2407-3-9 · Cited by 58
Deoxycorticosterone inactivation by AKR1C3 in human mineralocorticoid target tissues
Sharma, K. K., Lindqvist, A., Zhou, X. J., Auchus, R. J., Penning, T. M., & Andersson, S. (2006) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2005.10.024 · Cited by 57
Self-citationPhenotypic screening of hepatocyte nuclear factor (HNF) 4-γ receptor knockout mice
Gerdin, A.-K., Surve, V. V., Jönsson, M., Bjursell, M., Björkman, M., Edenro, A., Schuelke, M., Saad, A. M., Bjurström, S., Lundgren, E. J., et al. (2006) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2006.08.103 · Cited by 55
Matsunaga, T., Endo, S., Maeda, S., Ishikura, S., Tajima, K., Tanaka, N., Nakamura, K., Imamura, Y., & Hara, A. (2008) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2008.06.002 · Cited by 54
Byrns, M. C. (2013) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2013.01.015 · Cited by 55
Ebert, B., Kisiela, M., Wsól, V., & Maser, E. (2011) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2010.12.026 · Cited by 57
Hellgren, C., Comasco, E., Skalkidou, A., & Poromaa, I. S. (2017) · Hormones and Behavior · doi:10.1016/j.yhbeh.2017.06.008 · Cited by 55
Modulation of AKR 1C2 by curcumin decreases testosterone production in prostate cancer
Ide, H., Lü, Y., Noguchi, T., Muto, S., Okada, H., Kawato, S., & Horie, S. (2018) · Cancer Science · doi:10.1111/cas.13517 · Cited by 57
Penning, T. M. (2015) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2015.05.010 · Cited by 56
Self-citationRecent advances in 17beta-hydroxysteroid dehydrogenases
Prehn, C. P., Möller, G., & Adamski, J. (2009) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2008.12.024 · Cited by 56
Holterhus, P., Hiort, O., Demeter, J., Brown, P. O., & Brooks, J. D. (2003) · Genome biology · doi:10.1186/gb-2003-4-6-r37 · Cited by 55
Structure-based Inhibitor Design for an Enzyme That Binds Different Steroids
Qiu, W., Zhou, M., Mazumdar, M., Azzi, A., Ghanmi, D., Luu-The, V., Labrie, F., & Lin, S. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m606784200 · Cited by 54
Olsson, M., Gustafsson, O., Skogastierna, C., Tolf, A., Rietz, B. D., Morfin, R. F., Rane, A., & Ekström, L. (2007) · The Prostate · doi:10.1002/pros.20630 · Cited by 53
He, X., Węgiel, J., Yang, Y., Pullarkat, R. K., Schulz, H., & Yang, S. (2004) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2004.08.011 · Cited by 54
Stoffel‐Wagner, B., Watzka, M., Steckelbroeck, S., Ludwig, M. Z., Clusmann, H., BIDLINGMAIER, F., Casarosa, E., Luisi, S. V., Elger, C. E., & Beyenburg, S. (2003) · Epilepsy Research · doi:10.1016/s0920-1211(03)00036-6 · Cited by 53
Ragel, B. T., Couldwell, W. T., Gillespie, D. L., & Jensen, R. L. (2007) · Neurosurgical Review · doi:10.1007/s10143-007-0070-z · Cited by 53
Cloning and Characterization of AKR4C14, a Rice Aldo–Keto Reductase, from Thai Jasmine Rice
Narawongsanont, R., Kabinpong, S., Auiyawong, B., & Tantitadapitak, C. (2011) · The Protein Journal · doi:10.1007/s10930-011-9371-8 · Cited by 53
Indole-3-Carbinol and Its Role in Chronic Diseases
Licznerska, B. E., & Baer‐Dubowska, W. (2016) · Advances in experimental medicine and biology · doi:10.1007/978-3-319-41334-1_6 · Cited by 53
Lin, S., Shi, R., Qiu, W., Azzi, A., Zhu, D.-W., Dabbagh, H., & Zhou, M. (2006) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2005.11.035 · Cited by 53
Vergnes, L., Phan, J., Stolz, A., & Reue, K. (2003) · Journal of Lipid Research · doi:10.1194/jlr.m200399-jlr200 · Cited by 52
Drury, J. E., Mindnich, R., & Penning, T. M. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.127779 · Cited by 51
Self-citationPenning, T. M. (2011) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2011.01.009 · Cited by 50
Self-citationNew frontiers in androgen biosynthesis and metabolism
Penning, T. M. (2010) · Current Opinion in Endocrinology, Diabetes & Obesity · doi:10.1097/med.0b013e3283381a31 · Cited by 51
Self-citationAlbalat, R., Brunet, F., Laudet, V., & Schubert, M. (2011) · Genome Biology and Evolution · doi:10.1093/gbe/evr084 · Cited by 51
Identification of the molecular switch that regulates access of 5α-DHT to the androgen receptor
Penning, T. M., Bauman, D. R., Jin, Y., & Rižner, T. L. (2007) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2006.12.007 · Cited by 50
Self-citation
Metadata
- Authors
- PENNING, T. M., BURCZYNSKI, M. E., JEZ, J. M., HUNG, C.-F., LIN, H.-K., MA, H., MOORE, M., PALACKAL, N., & RATNAM, K.
- Affiliations
- University of Pennsylvania (US)
- Venue
- Biochemical Journal
- Publisher
- Portland Press Ltd.
- Published
- 2000-09-26
- Volume
- 351
- Issue
- 1
- Pages
- 67-77
- ISSN
- 0264-6021 (ISSN-L)
- 1470-8728
- PMC
- PMC1221336
- OpenAlex
- W2045040068
- Cited by
- 649
- References
- 38
- Citations by year
- 2026: 21 · 2025: 20 · 2024: 23 · 2023: 15 · 2022: 15 · 2021: 27 · 2020: 19 · 2019: 22 · 2018: 23 · 2017: 18 · 2016: 23 · 2015: 14 · 2014: 47 · 2013: 28 · 2012: 29
- FWCI
- 6.29
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Biochemical Journal (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institute of Diabetes and Digestive and Kidney Diseases (DK-47015, R01DK047015)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Aldose Reductase and Taurine
- Physical Sciences › Chemistry › Organic Chemistry › Steroid Chemistry and Biochemistry
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hormonal Regulation and Hypertension
- Keywords
- 3α-hydroxysteroid dehydrogenase, aldo-keto reductase superfamily, steroid hormone metabolism, dihydrotestosterone, testosterone, estradiol, progesterone, 20alpha-dihydroprogesterone, 3α-androstanediol, enzyme kinetic parameters, substrate specificity
- MeSH terms
- Androgens, Binding Sites, Catalysis, Cloning, Molecular, Estrogens, Female, Humans, Isoenzymes, Ketones, Kinetics, Male, Organ Specificity, Progestins, Recombinant Proteins, RNA, Messenger, Steroids, Substrate Specificity, 3-Hydroxysteroid Dehydrogenases, Reverse Transcriptase Polymerase Chain Reaction, Gene Expression Profiling, 3-alpha-Hydroxysteroid Dehydrogenase (B-Specific)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
